Torrent Pharmaceuticals Limited (BOM:500420)
4,341.95
-29.10 (-0.67%)
At close: Mar 4, 2026
Torrent Pharmaceuticals Revenue
Torrent Pharmaceuticals had revenue of 33.03B INR in the quarter ending December 31, 2025, with 17.59% growth. This brings the company's revenue in the last twelve months to 127.42B, up 12.74% year-over-year. In the fiscal year ending March 31, 2025, Torrent Pharmaceuticals had annual revenue of 115.16B with 7.35% growth.
Revenue (ttm)
127.42B
Revenue Growth
+12.74%
P/S Ratio
11.53
Revenue / Employee
7.47M
Employees
17,059
Market Cap
1.47T
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 115.16B | 7.88B | 7.35% |
| Mar 31, 2024 | 107.28B | 11.08B | 11.51% |
| Mar 31, 2023 | 96.20B | 11.12B | 13.07% |
| Mar 31, 2022 | 85.08B | 5.03B | 6.29% |
| Mar 31, 2021 | 80.05B | 652.60M | 0.82% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 345.83B |
| Lupin | 261.51B |
| Jubilant Pharmova | 79.18B |
| Abbott India | 68.24B |
| Granules India | 50.92B |
| J. B. Chemicals & Pharmaceuticals | 41.93B |
| GlaxoSmithKline Pharmaceuticals | 38.01B |
| AstraZeneca Pharma India | 21.77B |
Torrent Pharmaceuticals News
- 5 days ago - Why Are Shares Of Xeris Biopharma Falling Friday? - Benzinga
- 10 days ago - Macquarie initiates coverage on Torrent Pharma with outperform, sets target price for stock at Rs 5,000 - Business Upturn
- 17 days ago - Torrent Pharma shares rally over 5% as Q3 revenue jumps 17.6% YoY to Rs Rs 3,303 crore, net profit up 26.2% - Business Upturn
- 19 days ago - Torrent Pharmaceuticals Ltd (BOM:500420) Q3 2026 Earnings Call Highlights: Robust Revenue ... - GuruFocus
- 19 days ago - Q3 2026 Torrent Pharmaceuticals Ltd Earnings Call Transcript - GuruFocus
- 20 days ago - Torrent Pharmaceuticals Ltd (NSE:TORNTPHARM) Q3 2026 Earnings Report Preview: What To Look For - GuruFocus
- 6 weeks ago - Torrent Pharmaceuticals in focus as government panel clears key hurdle for Semaglutide tablets - Business Upturn
- 2 months ago - Torrent Pharmaceuticals approves Rs 12,500 crore NCD issuance via private placement - Business Upturn